Sermorelin certificate of analysis explained: what to check

Last updated 2026-07-24

What is a sermorelin certificate of analysis?

A certificate of analysis, almost always shortened to COA, is a document from a testing lab that reports what's actually in a specific batch (lot) of a product. For sermorelin, that means confirming the vial contains sermorelin acetate (not a different peptide or filler), stating how pure it is, and flagging anything it shouldn't contain: bacteria, endotoxins, heavy metals, or residual solvents left over from synthesis. Think of it as a batch-specific ID check, not a general product claim. A COA that says 'Sermorelin, 99.1% purity, Lot #SM-2024-0347' is telling you about that lot, made on a specific date, tested on a specific date. It says nothing about the lot sitting on a shelf next to it unless the numbers match. This matters more for sermorelin than for most consumer products because sermorelin sold outside a licensed pharmacy is typically labeled 'research use only,' meaning it hasn't gone through FDA review for human use in that form. The COA is often the only independent check a buyer has on what's actually in the vial. It is not a substitute for FDA approval, and it's not evidence the product is legal or safe to inject.

Why does sermorelin need a COA if it's a real, FDA-approved drug?

Sermorelin acetate itself has a real regulatory history. It was approved by the FDA and marketed in the US under the brand name Geref for diagnosing growth hormone deficiency, and Geref Diagnostic was used similarly ^[1]. The original Geref product was discontinued by the manufacturer for business reasons; it was not pulled for a safety recall. That's a genuinely useful fact, and one most peptides sold online can't claim. But that approval history covers a specific manufactured drug product, made under FDA-inspected conditions, with FDA oversight of the manufacturing process itself. It does not cover the sermorelin sold today by compounding pharmacies or online 'research chemical' vendors, which are separate supply chains with different oversight. Compounded sermorelin, when prescribed and dispensed through a licensed US compounding pharmacy under section 503A of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 353a) or from a 503B outsourcing facility (21 U.S.C. § 353b), is subject to state pharmacy board oversight and FDA rules on compounding ^[2]. That's a meaningfully different, more regulated path than a vial bought from a website with no prescription requirement. In that second category, a COA is one of the only paper trails a buyer has, and it's why checking one carefully actually matters here in a way it wouldn't for, say, a bottle of ibuprofen.

What should a legitimate sermorelin COA actually show?

A real, useful COA has specific fields, more than a purity percentage. If any of the following are missing, treat the document as decorative rather than proof. Lot number or batch number: this must match the lot number printed on your vial's label exactly. If the seller can't tell you how to find the lot number on your product, that's a problem. Test date and manufacture date: a COA tested three years ago tells you nothing about a vial made last month. Identity confirmation: usually done by mass spectrometry, confirming the molecule is actually sermorelin (or sermorelin acetate) and not a different, cheaper peptide. Purity percentage: typically reported by high-performance liquid chromatography (HPLC). Reputable synthetic peptide COAs commonly report 98% or higher purity; anything meaningfully below that, or unreported, is a red flag. Endotoxin level: reported in EU/mg (endotoxin units per milligram). This matters because bacterial endotoxins can cause fever, chills, or worse if injected, even in a sterile-looking clear solution. Heavy metals and residual solvents: less commonly reported by smaller labs, but present on higher-quality COAs. Testing lab name and accreditation: an independent third-party lab (not the seller's own in-house lab) with a real address and, ideally, ISO/IEC 17025 accreditation, is far more trustworthy than an unnamed lab or one that shares an owner with the seller. ISO/IEC 17025 is the general international standard for the competence of testing and calibration laboratories, maintained by the International Organization for Standardization ^[3].

How do you verify a COA is real and not faked or reused?

Start by checking whether the lot number on the COA matches the lot number on your vial label. This sounds obvious, but it's the single most common failure point: sellers post one 'representative' COA on their site and ship vials from a totally different, untested batch. Next, search for the testing lab independently. If the COA names a lab, look the lab up on its own website, not through a link the seller provides. Confirm it's a real, operating lab that does peptide testing, not a shell name with no web presence. Call or email the lab directly if you can, and ask if they tested that specific lot number. Legitimate labs can generally confirm this, though some require the seller's permission to release details to a third party. Be suspicious of COAs that are image files with no lab letterhead, no lab contact information, or oddly rounded numbers (a suspiciously clean '99.9%' across every single batch, forever, is a sign someone is reusing one template rather than running new tests). Finally, check the date math. A vial with a 2-year shelf life shouldn't have a COA dated from testing done 4 years ago.

Sermorelin vs HGH: which one actually needs this level of scrutiny?

This is the question most people researching sermorelin actually want answered, so let's be direct about it. Sermorelin is a growth-hormone-releasing hormone (GHRH) analog. It doesn't contain growth hormone itself; it signals your pituitary gland to produce and release its own GH ^[4]. HGH (somatropin) is the hormone itself, given directly. That difference changes both the pharmacology and the manufacturing stakes. Because sermorelin only nudges your own pituitary, a batch that's slightly underdosed or partially degraded mostly just does less. It's a milder failure mode. A contaminated or mislabeled batch of injectable HGH, by contrast, delivers a much more potent, bioactive protein directly, and errors in purity or dosing carry a higher physiological stake per microgram. Sermorelin also depends on a working pituitary gland; it does nothing useful for someone whose pituitary can't respond, and it produces a smaller, more physiologic rise in GH and IGF-1 than direct HGH injection, since it's still bounded by the body's own feedback loops ^[4][5]. That's arguably a safety feature, more than a limitation: overshoot is harder. HGH, dosed directly, bypasses that feedback loop entirely, which is part of why HGH carries a more serious side effect profile at supraphysiologic doses (joint pain, fluid retention, insulin resistance) and a longer list of FDA-recognized approved uses and monitoring requirements ^[6]. Where sermorelin is the weaker choice: if someone needs a large, reliable, guaranteed rise in GH and IGF-1 quickly (post-surgical wasting, certain confirmed deficiency states), HGH is the more predictable tool because it's dosed directly rather than depending on a gland's response. Sermorelin is the gentler, more conservative option for adults with mild age-related decline in GH secretion, but it is not a stronger or equivalent substitute for medically indicated HGH therapy, and nobody should expect sermorelin to replace HGH for a confirmed deficiency. For a full breakdown of mechanism and evidence, see sermorelin.

What's the difference between a pharmacy-dispensed COA and a research-chemical COA?

A compounded, prescription sermorelin from a licensed US pharmacy comes with a different kind of paper trail. Compounding pharmacies operating under 503A or 503B rules are inspected by state boards of pharmacy and, for 503B facilities, registered with and inspected by the FDA ^[2]. Their quality documentation is tied to a pharmacy license, more than a self-issued lab report. A research-chemical seller, by contrast, is usually not a licensed pharmacy at all. It sells 'for laboratory research only, not for human consumption,' language that exists specifically to sidestep FDA drug regulations. Any COA from this channel is voluntary; there's no regulatory body checking that the COA on the website matches what's actually shipped. That doesn't mean every research-chemical COA is fake, but it does mean the burden of verification sits entirely on the buyer, with no pharmacy board or FDA inspection standing behind it. If you want the pharmacy-backed path instead of the COA-verification path, that generally means going through a licensed telehealth provider who prescribes and routes the order to a licensed compounding pharmacy, rather than buying directly from a peptide vendor's website.

What purity percentage is actually good enough?

Most legitimate peptide COAs report purity in the 98% to 99.9% range using HPLC. Below 95%, you're looking at a meaningfully impure product, and impurities in peptide synthesis are usually truncated or deletion sequences (incomplete versions of the peptide) rather than exotic contaminants, but they still reduce potency and can affect how your body reacts. Here's a rough guide for reading the number, not a guarantee of safety: | Reported purity | What it likely means |

Does a COA prove the product is safe or legal to use?

No, and this is worth being blunt about. A COA is a snapshot of chemical content in one tested sample from one lot. It doesn't confirm the vial you receive was handled at the right temperature during shipping, stored correctly before you got it, or reconstituted properly. It also doesn't make an unapproved, non-prescription sermorelin product legal to buy, sell, or use in humans. Sermorelin itself, as a molecule, has FDA history via Geref ^[1]. But most sermorelin sold today outside a prescription pathway is marketed as research-use-only, which is a legal label meant for lab use, not human injection, regardless of what the COA says about purity. A good COA reduces one specific risk: getting something other than what's labeled, in the wrong amount, or contaminated with bacteria or toxins. It does not address the separate question of whether buying and using it outside a prescription relationship is a good idea, or where you fall under FDA and state pharmacy law. For that, a conversation with a licensed prescriber matters more than any lab report.

How is sermorelin actually dosed, and does the COA affect the dose you use?

Sermorelin is typically dosed as a subcutaneous injection, historically studied at doses like 1 mcg/kg for diagnostic GH stimulation testing per the original Geref labeling reviewed by FDA, though therapeutic maintenance dosing used off-label today is generally much lower and individualized by a prescriber, commonly in the 200 to 300 mcg per day range, given at bedtime to work with the body's natural nighttime GH pulse ^[1][4]. A COA does connect to dosing in one practical way: if the reported purity is 95% instead of 99%, and you're drawing up a dose based on the labeled concentration, you're technically getting slightly less active peptide per draw than the label implies. For sermorelin, given its wide margin and self-limiting mechanism, this is a minor issue in practice, more relevant to consistency than to safety. It's a bigger deal with a genuinely underdosed or degraded vial, where purity issues compound with concentration issues (a vial that's both mislabeled in concentration and impure is a worse problem than either alone). For specific numbers and titration schedules, see the sermorelin dosage chart and the sermorelin dosage calculator. Those tools assume you're starting from a product that's actually what it claims to be, which loops right back to why the COA check comes first.

What red flags in a COA (or its absence) should make you walk away?

A few patterns come up again and again with sketchy sermorelin sellers, and any one of them is reason enough to look elsewhere. No COA offered at all, or one available only 'on request' that never actually arrives. A COA with a lot number that doesn't match your vial, or no lot number listed anywhere on the product. The same COA image reused across multiple product listings or multiple 'different' peptides. No named, independently checkable testing lab, just a logo or an unverifiable name. No endotoxin or sterility data at all, only a purity number. Prices dramatically below the going market rate, paired with vague or absent testing claims. Cheap and untested is a worse combination than expensive and untested, but neither is good. No prescription requirement and no involvement of a licensed pharmacy anywhere in the transaction. If you're seeing more than one of these, the safer route is a provider-reviewed path where a licensed prescriber evaluates you and the product is dispensed through a licensed pharmacy, rather than trying to verify a stranger's lab report yourself. Sermorelin Co's provider-reviewed process connects you with a prescriber and routes fulfillment through a licensed pharmacy partner rather than a direct-to-consumer peptide seller, which sidesteps the entire COA-verification problem by moving the quality control upstream to the pharmacy and prescriber relationship instead of leaving it on you.

How does this compare across sermorelin, other GH peptides, and HGH itself?

Frequently asked questions

What is a sermorelin certificate of analysis used for?

It's a lab report confirming what's actually in a specific manufactured lot of sermorelin: identity (is it really sermorelin), purity percentage, and levels of contaminants like bacterial endotoxins or heavy metals. It's a quality check on one batch, not a general safety or legality certification for the product line as a whole.

Is sermorelin FDA approved?

Sermorelin was FDA-approved and marketed in the US as Geref for diagnosing growth hormone deficiency ^[1]. The branded product was later discontinued by the manufacturer for business reasons, not pulled for safety. Most sermorelin sold today is either compounded by a licensed pharmacy under a prescription or sold as an unapproved research chemical.

Why was Geref discontinued if sermorelin is safe?

Geref's discontinuation reflected a manufacturer business decision, not an FDA safety withdrawal or recall. Drugs get discontinued for many non-safety reasons: low demand, manufacturing cost, or a company shifting priorities. FDA's Orange Book and discontinuation notices don't list it as pulled for a safety signal ^[1].

What purity percentage should a sermorelin COA show?

Reputable peptide COAs typically report 98% to 99.9% purity by HPLC. Purity in the 90-95% range is lower quality and worth questioning. Below 90%, or no purity figure at all, is a real red flag. Purity alone doesn't confirm sterility, so also check for endotoxin testing.

Is sermorelin the same as HGH?

No. Sermorelin is a growth-hormone-releasing hormone analog that signals your pituitary to make and release its own GH. HGH (somatropin) is the growth hormone itself, given directly. Sermorelin produces a smaller, more physiologic response bounded by your body's feedback loops; HGH bypasses that loop entirely ^[3][4].

Can a fake COA look convincing?

Yes. Anyone with basic design software can produce a document that looks like a lab report. The way to catch a fake isn't to eyeball it for professionalism; it's to verify the lot number matches your vial and independently confirm the named testing lab actually exists and tested that batch.

Does a COA guarantee the product is sterile?

No. A COA that only reports purity says nothing about sterility. Look specifically for endotoxin testing (reported in EU/mg) and microbial testing, referenced against pharmacopeial standards like USP <85> ^[7]. A high purity number with no sterility or endotoxin data is an incomplete picture and shouldn't be treated as proof the product is safe to inject.

How is sermorelin dosed compared to HGH?

Sermorelin is typically injected subcutaneously at bedtime, with therapeutic maintenance doses commonly cited in the low hundreds of micrograms per day, individualized by a prescriber ^[3]. HGH is dosed more precisely to achieve a target IGF-1 level under closer medical monitoring, since it acts directly rather than through the body's own regulatory feedback.

Where can I buy legitimate, tested sermorelin?

The lowest-verification-burden path is a prescription from a licensed provider, filled by a licensed compounding pharmacy, rather than a direct-to-consumer research-chemical seller. See sermorelin peptide near me for how to find a provider-reviewed option in your area.

What's the difference between a 503A and 503B compounding pharmacy?

Both compound medications not available in FDA-approved commercial form. 503A pharmacies compound for individual patients with a prescription and are regulated mainly by state boards of pharmacy. 503B outsourcing facilities compound in larger batches, register with the FDA, and follow current good manufacturing practice requirements ^[2].

Are there long-term risks from using sermorelin with an unverified COA?

The main risks aren't from sermorelin itself but from what might be in an unverified vial: bacterial contamination, incorrect concentration, or a different peptide entirely. See sermorelin long-term side effects for what's documented about sermorelin's own safety profile when properly sourced and dosed.

Should I trust a seller who won't provide a COA at all?

No. A legitimate seller of any peptide product should be able to provide a current, lot-matched COA from a named, independent lab without hesitation. Refusal, delay, or vague answers about testing is one of the clearest signals to buy elsewhere or pursue a prescription-based route instead.

Sources

1. FDA, Drugs@FDA database entry for Geref (sermorelin acetate), NDA 019826: Sermorelin was FDA-approved and marketed as Geref for diagnosing growth hormone deficiency; the product was discontinued rather than withdrawn for safety
2. 21 U.S.C. § 353a and § 353b, Federal Food, Drug, and Cosmetic Act, compounding provisions: 503A and 503B compounding pharmacies are subject to state board and/or FDA oversight distinct from unregulated research-chemical sellers
3. Corpas E, Harman SM, Blackman MR, "Human Growth Hormone and Human Aging," Endocrine Reviews, 1993, PMID 8319585: Sermorelin, a GHRH analog, works by stimulating the pituitary gland to produce and release its own growth hormone rather than supplying growth hormone directly
4. Molitch ME, et al., "Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline," Journal of Clinical Endocrinology & Metabolism, 2011, PMID 21593107: Growth hormone secretion and IGF-1 response are regulated by feedback loops that differ between GHRH-stimulated release and direct exogenous HGH administration
5. FDA, Genotropin (somatropin) prescribing information approval, NDA 020280: FDA-approved HGH products carry defined approved indications and monitoring requirements distinct from compounded or unapproved GHRH analogs
6. International Organization for Standardization, ISO/IEC 17025:2017 General requirements for the competence of testing and calibration laboratories: ISO/IEC 17025 is the general international accreditation standard for the competence of testing and calibration laboratories
7. United States Pharmacopeia, General Chapter <85> Bacterial Endotoxins Test: USP General Chapter <85> sets the bacterial endotoxin test methods and limits used as a reference standard for injectable products
8. 21 U.S.C. § 321(g), Federal Food, Drug, and Cosmetic Act definition of "drug": Products intended for use in humans in the diagnosis, cure, mitigation, treatment, or prevention of disease meet the legal definition of a drug requiring FDA oversight, which is why research-use-only labeling on sermorelin sold for human injection sits outside normal drug regulation